** Shares of Alcidion Group Ltd ALC.AX rise as much as 20.8% to A$0.145, their highest level since February 24, 2023
** The healthcare technology firm generates FY25 new total contract value $(TCV)$ sales of A$73.8 million ($48.82 million), up 10.9% from a year earlier
** Reconfirms outlook of FY25 EBITDA exceeding A$4.5 mln
** Co will release FY25 earnings results and FY26 guidance on August 28
** Around 5.7 mln shares change hands, 4.4x the 30-day avg
** Stock last up 4.2%, bringing YTD gains to 108.3%
($1 = 1.5117 Australian dollars)
(Reporting by Shruti Agarwal in Bengaluru)
((Shruti.Agarwal@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。